Crain's Chicago Business3d
Xeris enters a whole new market for one of its main pharma offerings
Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal ...
Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...
Medical News Today12d
Gvoke (glucagon) and cost
However, glucagon (the active drug in Gvoke ... prescribed (such as the Gvoke HypoPen auto-injector, Gvoke prefilled syringe, or Gvoke prefilled vial and syringe kit) These same factors may ...
Hosted on MSN1mon
GLP-1 medications can have adverse side effects if taken incorrectly, experts say
(WBRC) - Glucagon-like peptide-1 (GLP-1 ... and what that may actually look like on your syringe in case you are drawing it up yourself.” If you are worried you administered a medication ...
pharmaphorum2d
CHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugar
In the US, Baqsimi is now competing head-to-head with Xeris’ Gvoke, pre-filled syringe and pen injector formulations of glucagon that don’t require the mixing steps and can be used in patients ...